Literature DB >> 19370328

[Percutaneous aortic valve replacement - pro].

Lutz Buellesfeld1, Eberhard Grube.   

Abstract

Percutaneous aortic valve replacement is presently on its way to revolutionize the current treatment practice for patients with degenerative aortic valve stenosis. Two different techniques are available: the balloon-expandable Edwards valve prosthesis and the self-expanding CoreValve ReValving prosthesis. After an initial learning curve as well as device modifications, use of the current generations has a > 95% success rate with a low peri- and post-interventional complication rate. In this article, an overview on the current status of this technique will be provided.

Entities:  

Mesh:

Year:  2009        PMID: 19370328     DOI: 10.1007/s00059-009-3213-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  73 in total

Review 1.  [Mechanisms of inflammation in heart failure].

Authors:  Martin Fuchs; Helmut Drexler
Journal:  Herz       Date:  2004-12       Impact factor: 1.443

2.  Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Noriko Kuwae; Dennis Y Wu; Ronney S Shantouf; Denis Fouque; Stefan D Anker; Gladys Block; Joel D Kopple
Journal:  Am J Clin Nutr       Date:  2006-02       Impact factor: 7.045

3.  Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure.

Authors:  P Ponikowski; T P Chua; S D Anker; D P Francis; W Doehner; W Banasiak; P A Poole-Wilson; M F Piepoli; A J Coats
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

4.  Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.

Authors:  S D Anker; F Leyva; P A Poole-Wilson; W J Kox; J C Stevenson; A J Coats
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

5.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Authors:  J Niebauer; H D Volk; M Kemp; M Dominguez; R R Schumann; M Rauchhaus; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

Review 6.  Prognosis and therapy approaches of cardiac cachexia.

Authors:  Jochen Springer; Gerasimos Filippatos; Yoshihiro J Akashi; Stefan D Anker
Journal:  Curr Opin Cardiol       Date:  2006-05       Impact factor: 2.161

7.  Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.

Authors:  Tibor Kempf; Stephan von Haehling; Timo Peter; Tim Allhoff; Mariantonietta Cicoira; Wolfram Doehner; Piotr Ponikowski; Gerasimos S Filippatos; Piotr Rozentryt; Helmut Drexler; Stefan D Anker; Kai C Wollert
Journal:  J Am Coll Cardiol       Date:  2007-08-24       Impact factor: 24.094

8.  Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

Authors:  Rakesh Sharma; Darrel P Francis; Bertram Pitt; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

9.  Cachexia: common, deadly, with an urgent need for precise definition and new therapies.

Authors:  Mitja Lainscak; Gerasimos S Filippatos; Mihai Gheorghiade; Gregg C Fonarow; Stefan D Anker
Journal:  Am J Cardiol       Date:  2008-06-02       Impact factor: 2.778

10.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

Authors:  Darlington O Okonko; Agnieszka Grzeslo; Tomasz Witkowski; Amit K J Mandal; Robert M Slater; Michael Roughton; Gabor Foldes; Thomas Thum; Jacek Majda; Waldemar Banasiak; Constantinos G Missouris; Philip A Poole-Wilson; Stefan D Anker; Piotr Ponikowski
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

View more
  7 in total

1.  Conformational constraints on side chains in protein residues increase their information content.

Authors:  A J Bojarski; M Nowak; B Testa
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

Review 2.  Novel estrogen receptor coregulators and signaling molecules in human diseases.

Authors:  C J Barnes; R K Vadlamudi; R Kumar
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

3.  Vascular access site complications after percutaneous transfemoral aortic valve implantation.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Marcel Weber; Daniel Wendt; Torsten Heine; Eva Kottenberg; Matthias Thielmann; Hilmar Kühl; Jürgen Peters; Heinz G Jakob; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

4.  [Experience and learning curve with transapical aortic valve implantation].

Authors:  Daniel Wendt; Holger Eggebrecht; Philipp Kahlert; Torsten Heine; Eva Kottenberg; Parwis Massoudy; Markus Kamler; Jürgen Peters; Raimund Erbel; Heinz Jakob; Matthias Thielmann
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

Review 5.  [Percutaneous approaches for mitral valve interventions--a real alternative technique for standard cardiac surgery?].

Authors:  Christian Frerker; Ulrich Schäfer; Dimitry Schewel; Matthias Krüger; Rainer Malisius; Carsten Schneider; Stephan Geidel; Martin Bergmann; Karl-Heinz Kuck
Journal:  Herz       Date:  2009-09       Impact factor: 1.443

6.  Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes.

Authors:  I W Nilsen; B Myrnes; R B Edvardsen; D Chourrout
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

7.  Olfactory ensheathing cell phenotype following implantation in the lesioned spinal cord.

Authors:  E Woodhall; A K West; J C Vickers; M I Chuah
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.